Human tumor antigens recognized by T lymphocytes: Implications for cancer therapy

Journal of Leukocyte Biology

Volumn 60, Issue 3, 1996, Pages 296-309

  Wang, Rong Fu ^a   Rosenberg, Steven A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Autoimmune disease; Cyclin dependent kinase 4; Interleukin 2; catenin

Indexed keywords

BETA CATENIN; COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 4; INTERLEUKIN 2; TUMOR ANTIGEN; TYROSINASE RELATED PROTEIN; UNCLASSIFIED DRUG;

ADOPTIVE IMMUNOTHERAPY; AUTOIMMUNITY; CANCER IMMUNOTHERAPY; HUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0029814705     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.60.3.296     Document Type: Review

References (120)

1. Rosenberg, S. A., Spiess, P., Lafreniere, R. (1986) A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science 233, 1318-1321.
2. Kast, W. M., Offringa, R., Peters, P. J., Voordouw, A. C., Meloen, R. H., Van der Eb, A. J., Melief, C. J. M. (1989) Eradication of adenovirus E1-induced tumors by E1A specific cytotoxic T lymphocytes. Cell 59, 603-614.
3. Greenbeerg, P. D. (1991) Adoptive T cell therapy of tumors: mechanisms operative in the recognition and elimination of tumor cells. Adv. Immunol. 49, 281-355.
4. Rosenberg, S. A., Packard, B. S., Aebersold, P. M., Solomon, D., Topalian, S. L., Toy, S. T., Simon, P., Lotze, M. T., Yang, J. C., Seipp, C. A., Simpson, C., Carter, C., Bock, S., Schwartzentruber, D., Wei, J. P., White, D. E. (1988) Use of tumor infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. Preliminary report. N. Engl. J. Med. 319, 1676-1680.
5. Rosenberg, S. A. (1992) The immunotherapy and gene therapy of cancer. J. Clin. Oncol. 10, 180-199.
6. Van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., DePlaen, E., Van Den Eynde, B., Knuth, A., Boon, T. (1991) A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254, 1643-1647.
7. Kawakami, Y., Eliyahu, S., Delgaldo, C. H., Robbins, P. F., Rivoltini, L., Topalian, S. L., Miki, T., Rosenberg, S. A. (1994) Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. Natl. Acad. Sci. USA 91, 3515-3519.
8. Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Sakaguchi, K., Appella, E., Yannelli, J. R., Adema, G. J., Miki, T., Rosenberg, S. A. (1994) Identification of a human melanoma antigen recognized by tumor infiltrating lymphocytes associated with in vivo tumor rejection. Proc. Natl. Acad. Sci. USA 91, 6458-6462.
9. Brichard, V., Van Pel, A., Wölfel, T., Wölfel, C., De Plaen, E., Lethë, B., Coulie, P., Boon, T. (1993) The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 178, 489-495.
10. Coulie, P. G., Brichard, V., Van Pel, A., Wolfel, T., Schneider, J., Traversari, C., Mattei, S., De Plaen, E. D., Lurquin, C., Szikora, J-P., Reauld, J-C., Boon, T. (1994) A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 180, 35-42.
11. Gaugler, B., Van Den Eynde, B., Van der Bruggen, P., Romero, P., Caforio, J. J., De Plaen, E., Lethe, B., Brasseur, F., Boon, T. (1994) Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. Exp. Med. 179, 921-930.
12. Van Den Eynde, B., Peeters, O., De Backer, O., Gaugler, B., Lucas, S., Boon, T. (1995) A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J. Exp. Med. 182, 689-698.
13. Boel, P., Wildmann, C., Sensi, M. L., Brasseur, R., Renauld, J. C., Coulie, P., Boon, T., Van der Bruggen, P. (1995) BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity 2, 167-175.
14. Robbins, P. F., El-Gamil, M., Kawakami, Y., Stevens, E., Yannelli, J., Rosenberg, S. A. (1994) Recognition of tyrosinase by tumor infiltrating lymphocytes from a patient responding to immunotherapy. Cancer Res. 54, 3124-3126.
15. Wang, R. F., Robbins, P. F., Kawakami, Y., Kang, X. Q., Rosenberg, S. A. (1995) Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes. J. Exp. Med. 181, 799-804.
16. Wolfel, T., Hauer, M., Schneider, J., Serrano, M., Wolfel, C., Klehmann-Hieb, E., De Plaen, E., Hankeln, T., Meyer Zum Buschenfelde, K.-H., Beach, D. (1995) A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science 269, 1281-1284.
17. Robbins, P. F., El-Gamil, M., Li, Y. F., Kawakami, Y., Loftus, D., Appella, E., Rosenberg, S. A. (1996) A mutated β-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes. J. Exp. Med. 183, 1185-1192.
18. Mandelbolm, O., Berke, G., Fridkin, M., Feldman, M., Eisenstein, M., Eisenbach, L. (1994) CTL induction by a tumor-associated antigen octapeptide derived from a murine lung carcinoma. Nature 369, 67-71.
19. Cox, A. L., Skipper, J., Cehn, Y., Henderson, R. A., Darrow, T. L., Shabanowitz, J., Engelhard, V. H., Hunt, D. F., Slingluff, C. L. (1994) Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science 264, 716-719.
20. Cheever, M. A., Disis, M. L., Bernhard, H., Gralow, J. R., Hand, S. L., Huseby, E. S., Qin, H. L., Takahashi, M., Chen, W. (1995) Immunity to oncogenic proteins. Immunol. Rev. 145, 33-59.
21. Fisk, B., Blevins, T. L., Wharton, J. T., Ioannides, C. G. (1995) Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines. J. Exp. Med. 181, 2109-2117.
22. Jung, S., Schluesener, H. J. (1991) Human T lymphocytes recognize a peptide of single point-mutated, oncogenic ras proteins. J. Exp. Med. 173, 273-276.
23. Skipper, J., Stauss, H. J. (1993) Identification of two cytotoxic T lymphocyte-recognized epitopes in the Ras protein. J. Exp. Med. 177, 1493-1498.
24. Celis, E., Tsai, V., Crimi, C., DeMars, R., Wentworth, P. A., Chesnut, R. W., Grey, H. M., Sette, A., Serra, H. M. (1994) Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes. Proc. Natl. Acad. Sci. USA 91, 2105-2109.
25. Rammensee, H. G., Friede, T., Stevanoviic, S. (1995) MHC ligands and peptide motifs: first listing. Immunogenetics 41, 178-228.
26. Traversari, C., Van der Bruggen, P., Luescher, I. F., Lurquin, C., Chomez, P., Van Pel, A., De Plaen, E., Amar-Costesec, A., Boon, T. (1992) A nonapeptide encoded by human gene MACE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J. Exp. Med. 176, 1453-1457.
27. Van der Bruggen, P., Szikora, J. -P., Boel, P., Wildmann, C., Somville, M., Sensi, M., Boon, T. (1994) Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing Cw1601. Eur. J. Immunol. 24, 2134-2140.
28. Van der Bruggen, P., Bastin, J., Gajewski, T., Coulie, P. G., Boel, P., de Smet, C., Traversari, C., Townsend, A., Boon, T. (1994) A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Eur. J. Immunol. 24, 3038-3043.
29. Guilloux, Y., Lucas, L., Brichard, V. G., Van Pel, A., Viret, C., De Plaen, E., Brasseur, F., Lethe, B., Jotereau, F., Boon, T. (1996) A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanoma is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene. J. Exp. Med. 183, 1173-1183.
30. Bouchard, B., Fuller, B. B., Vijayasaradhi, S., Houghton, A. N. (1989) Induction of pigmentation in mouse fibroblasts by expression of human tyrosinase cDNA. J. Exp. Med. 169, 2029-2042.
31. Wolfel, T., Van Pel, A., Brichard, V., Schneider, J., Seliger, B., Meyer Zum Buschenfelde, K.-H., Boon, T. (1994) Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes. Eur. J. Immunol. 24, 759-764.
32. Kang, X. -Q., Kawakami, Y., Sakaguchi, K., El-Gamil, M., Wang, R.-F., Yannelli, J. R., Appella, E., Rosenberg, S. A., Robbins, P. F. (1995) Identification of a tyrosinase epitope reocognized by HLA-A24 restricted tumor-infiltrating lymphocytes. J. Immunol. 155, 1343-1348.
33. Brichard, V. G., Herman, J., Van Pel, A., Wildmann, C., Gaugler, B., Wolfel, T., Boon, T., Lethe, B. (1996) A tyrosinase nonpeptide presented by HLA-B44 is recognized on a human melanoma by autologous cytolytic T lymphocytes. Eur. J. Immunol. 26, 224-230.
34. + T lymphocytes. J. Interferon Cytokine Res. 15, 739-746.
35. + T lymphocytes infiltrating human breast cancer recognize autologous tumor in an MHC-class II restricted fashion. Cancer Immunol. Immunother. 40, 1-9.
36. + T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene. Proc. Natl. Acad. Sci. USA 91, 9461-9465.
37. + T lymphocytes recognize human melanoma antigens processed and presented by Epstein-Barr-transformed B cells. Int. J. Cancer 58, 69-79.
38. + T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes. J. Exp. Med. In press.
39. + T lymphocytes against human melanoma. Evidence for a shared melanoma antigen presented by HLA-DR15. J. Immunol. 154, 772-779.
40. Kawakami, Y., Eliyahu, S., Sakaguchi, K., Robbins, P. F., Rivoltini, L., Yannelli, J. B., Appella, E., Rosenberg, S. A. (1994) Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2 restricted tumor infiltrating lymphocytes. J. Exp. Med. 180, 347-352.
41. Sensi, M., Traversari, C., Radrizzani, M., Salvi, S., Maccalli, C., Mortarini, R., Rivoltini, L., Farina, C., Nicolini, G., Wolfel, T., Brichard, V., Boon, T., Bordignon, C., Anichini, A., Parmiani, G. (1995) Cytotoxic T lymphocyte clones from different patients display limited T-cell receptors variable gene usage in HLA-A2 restricted recognition of Melan/MART-1 melanoma antigen. Proc. Natl. Acad. Sci. USA 92, 5674-5678.
42. Bakker, A. B. H., Schreurs, M. W. J., de Boer, A. J., Kawakami, Y., Rosenberg, S. A., Adema, G. J., Figdor, C. G. (1994) Melanocyte lineage-specific antigen gp100 is recognized by melanocyte-derived tumor-infiltrating lymphocytes. J. Exp. Med. 179, 1005-1009.
43. Adema, G. J., de Boer, A. J., van't Hullenaar, R., Denijn, M., Ruiter, D. J., Vogel, A. M., Figdor, C. G. (1993) Melanocyte lineage-specific antigens recognized by monoclonal antibodies NKl-beteb,HMB-50, and HMB-45 are encoded by a single cDNA. Am. J. Pathol. 143, 1579-1585.
44. Adema, G. J., Boer, A. J., Vogell, A. M., Loenen, W. A. M., Figdor, C. G. (1994) Molecular characterization of the melanocyte lineage-specific antigen gp100. J. Biol. Chem. 269, 20126-20133.
45. Kawakami, Y., Eliyahu, S., Jennings, C., Sakaguchi, K., Kang, X., Southwood, S., Robbins, P. F., Sette, A., Appella, E., Rosenberg, S. A. (1995) Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression. J. Immunol. 154, 3961-3968.
46. Bakker, A., Schreurs, M., Tafazzul, G., de Boer, A., Kawakami, Y., Adema, G., Figdor, C. (1995) Identification of a novel peptide derived from the melanocyte-specific gp100 antigen as the dominant epitope recognized by an HLA-A2.1-restricted anti-melanoma CTL line. Int. J. Cancer 62, 97-102.
47. + cytotoxic T lymphocytes. J. Exp. Med. 181, 363-368.
48. Wolfel, T., Schneider, J., Meyer Zum Buschenfelde, K.-H., Rammensee, H.-G., Rotzschke, O., Falk, K. (1994) Isolation of naturally processed peptides recognized by cytolytic T lymphocytes (CTL) on human melanoma cells in association with HLA-A2.1. Int. J. Cancer 57, 413-418.
49. Topalian, S., Solomon, D., Avis, F. P., Chang, A. E., Freeksen, D. L., Linehan, W. M., Lotze, M. T., Robertson, C. N., Seipp, C. A., Simon, P., Simpson, C. G., Rosenberg, S. A. (1988) Immunotherapy of patients with advanced cancer using tumor infiltrating lymphocytes and recombinant interleukin-2: a pilot study. J. Clin. Oncol. 6, 839-853.
50. Cohen, T., Muller, R. M., Tomita, Y., Shibahara, S. (1990) Nucleotide sequence of the cDNA encoding human tyrosinase-related protein. Nucleic Acids Res. 18, 2807-2808.
51. Vijayasyradhi, S., Bouchard, B. B., Houghton, A. N. (1990) The melanoma antigen gp75 is the human homologue of mouse b (brown) locus gene. J. Exp. Med. 171, 1375-1380.
52. Mattes, M. J., Thomson, T. M., Old, L. J., Lloyd, K. O. (1983) A pigmentation-associated, differentiation antigen of human melanoma defined by a precipitating antibody in human serum. Int. J. Cancer 32, 717-721.
53. Thomson, T. M., Real, F. X., Murakami, S., Cordon-Cardo, C., Old, L. J., Houghton, A. N. (1988) Differentiation antigens of melanocytes and melanoma: analysis of melanosome and cell surface markers of human pigmented cells with monoclonal antibodies. J. Invest. Dermatol. 90, 459-466.
54. Thomson, T. M., Mattes, J. M., Roux, L., Old, L. J., Lloyd, K. O. (1985) Pigmentation-associated glycoprotein of human melanoma and melanocytes: definition with a mouse monoclonal antibody. J. Invest. Dermatol. 85, 169-174.
55. Jimenez-Cervantes, C., Solano, F., Kobayashi, T., Urabe, K., Hearing, V. J., Lozano, J. A., Garcia-Borron, J. C. (1994) A new enzymatic function in the melanogenic pathway. J. Biol. Chem. 269, 17993-18001.
56. Falk, K., Rotzschke, O., Takiguchi, M., Grahovae, B., Gnau, V., Stevanovic, S., Jung, G., Rammensee, H.-G. (1994) Peptide motifs of HLA-A1, -A11, -A31, and -A33 molecules. Immunogenetics 40, 238-241.
57. Wang, R. F., Parkhuret, M. R., Kawakami, Y., Bobbins, P. F., Rosenberg, S. A. (1996) Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen . J. Exp. Med. 183, 1131-1140.
58. Descombes, P., Schibler, U. (1991) A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, UP, are translated from the same mRNA. Cell 67, 569-579.
59. Ossipow, V., Descombes, P., Schibler, U. (1993) CCAAT/enhancer-binding protein mRNA is translated into multiple proteins with different transcription activation potentials. Proc. Natl. Acad. Sci. VSA 90, 8219-8223.
60. Hann, S. R. (1995) Regulation and function of non-AUG-initiated proto-oncogenes. Biochimie 76, 880-886.
61. Shaw, M. W., Choppin, P. W., Lamb, R. A. (1983) A previously unrecognized influenza B virus glycoprotein from a bicistronic mRNA that also encodes the viral neuraminidase. Proc. Natl. Acad. Sci. VSA 80, 4879-4883.
62. Spiropoulou, C. F., Nichol, S. T. (1993) A small highly basic protein is encoded in overlapping frame within the P gene of vesicular stomatitis virus. J. Virol. 67, 3103-3110.
63. Schwartz, S., Felber, B. K., Pavlakis, G. N. (1992) Mechanism of translation of monocistronic and multicistronic human immunodeficiency virus type 1 mRNAs. Mol. Cell. Biol. 12, 207-219.
64. Townsend, A., Ohlen, C., Rogers, M., Edwards, J., Mukherjee, S., Bastin, J. (1994) Souce of unique tumor antigens. Nature 371, 662.
65. Serrano, M., Hannon, G. J., Beach, D. (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 [see comments]. Nature 366 ,704-707.
66. Sherr, C. J., Roberts, J. M. (1995) Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9, 1149-1163.
67. Quelle, D. E., Zindy, F., Ashmun, R. A., Sherr, C. J. (1995) Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83, 993-1000.
68. Uenaka, A., Ono, T., Akisawa, T., Wada, H., Yasuda, T., Nakayama, E. (1994) Identification of a unique antigen peptide pRL1 on BALB/c RL male 1 leukemia recognized by cytotoxic T lymphocytes and its relation to the Akt oncogene. J. Exp. Med. 180, 1599-1607.
69. b major histocompatibility complex class I molecule to alloreactive T cells. J. Exp. Med. 182, 1739-1750.
70. Robbins, P. F., El-Gamil, M., Li, Y. F., Topalian, S. L., Rivoltini, L., Sakaguchi, K., Appella, E., Kawakami, Y., Rosenberg, S. A. (1995) Cloning of a new gene encoding an antigen recognized by melanoma-specific HLA-A24 restricted tumor-infiltrating lymphocytes. J. Immunol. 154, 5944-5950.
71. Ioannides, C. G., Fisk, B., Pollack, M. S., Frazier, M. L., Wharton, J. T., Freedman, R. S. (1993) Cytotoxic T-cell clones isolated from ovarian tumour infiltrating lymphocytes recognize common determinants on nonovarian tumour clones. Scand. J. Immunol. 37, 413-424.
72. Fisk, B., Chesak, B., Pollack, M. S., Wharton, J. T., Ioannides, C. G. (1994) Oligopeptide induction of a cytotoxic T lymphocyte response to HER-2/Neu proto-oncogene in vitro. Cell Immunol. 157, 415-427.
73. 2/neu expression with sensitivity to tumor-specific CTL in human ovarian cancer. J. Immunol. 152, 2393-2400.
74. Disis, M. L., Alenoff, E. C., McLaughlin, G., Murphy, A. E., Chen, W., Groner, B., Jeschke, M., Lydon, N., McGlynn, E., Livingston, R. B., Moe, R., Cheever, M. A. (1994) Existent T cell and antibody immunity to HER-2/neu protein in patients with breast cancer. Cancer Res. 54, 16-20.
75. 2/neu-derived peptide. Proc. Natl. Acad. Sci. USA 92, 432-436.
76. Linehan, D. C., Goedegebuure, P. S., Peoples, G. E., Rogers, S. O., Eberlein, T. J. (1995) Tumor-specific and HLA-A2-restricted cytolysis by tumor-associated lymphocytes in human metastatic breast cancer. J. Immunol. 155, 4486-4491.
77. Finn, O. J. (1992) Antigen-specific, MHC-unrestricted T cells. Biotherapy 4, 239-249.
78. Ioannides, C. G., Fisk, B., Jerome, K. R., Irimura, T., Wharton, J. T., Finn, O. J. (1993) Cytotoxic T cells from ovarian malignant tumors can recognize polymorphic epithelial mucin core peptides. J. Immunol. 151, 3693-3703.
79. Magarian-Blander, J., Domenech, N., Finn, O. J. (1993) Specific and effective T-cell recognition of cells transfected with a truncated human mucin cDNA. Ann. NY Acad. Sci. 690, 231-243.
80. Finn, O. J., Jerome, K. R., Henderson, R. A., Pecher, G., Domenech, N., Barratt-Boyes Magarian-Blander, S. M. (1995) MUC-I epithelial tumor mucin-based immunity and cancer vaccines. Immunol. Rev. 145, 61-89.
81. Boon, T. (1992) Toward a genetic analysis of tumor rejection antigens. Adv. Cancer Res. 58, 177-210.
82. Monach, P. A., Meredith, S. C., Siegel, C. T., Schreiber, H. (1995) A unique tumor antigen produced by a single amino acid substitution. Immunol. 2, 45-59.
83. Van Elsas, A., Nijman, H. W., Van der Minne, C. E., Mourer, J. S., Kast, W. M., Melief, C. J., Schrier, P. I. (1995) Induction and characterization of cytotoxic T-lymphocytes recognizing a mutated p21ras peptide presented by HLA-A*0201. Int. J. Cancer 61, 389-396.
84. Houbiers, J. G. A., Nijman, H. W., van der Burg, S. H., Drijfhoul, J. W., Kenemans, P., van de Velde, C. J. H., Brand, A., Momburg, F., Kast, W. M., Melief, C. J. M. (1993) In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild-type p53. Eur. J. Immunol. 23, 2072-2077.
85. Nijman, H. W., van der Burg, S. H., Vierboom, M. P., Houbiers, J. G., Kast, W. M., Melief, C. J. (1994) p53, a potential target for tumor-directed T cells. Immunol. Lett. 40, 171-178.
86. Nijman, H. W., Houbiers, J. G. A., van der Burg, S. H., Vierboom, M. P. M., Kenemans, P., Kast, W. M., Melief, C. J. M. (1993) Characterization of cytotoxic T lymphocyte epitopes of a self-protein, p53, and a non-self-protein,influenza matrix: Relationship between major histocompatibility complex peptide binding affinity and immune responsiveness to peptides. J. Immunother 14, 121-126.
87. Theobald, M., Biggs, J., Dittmer, D., Levine, A. J., Sherman, L. A. (1995) Targeting p53 as a general tumor antigen. Proc. Natl. Acad. Sci. USA 92, 11993-11997.
88. Coulie, P. G., Lehmann, F., Lethe, B., Herman, J., Lurquin, C., Andrawiss, M., Boon, T. (1995) A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma. Proc. Natl. Acad. Sci. USA 92, 7976-7980.
89. Grunwald, G. B. (1993) The structural and functional analysis of cadherin calcium-dependent cell adhesion molecules. Curr. Op. Cell Biol. 5, 797-805.
90. Hoschuetzky, H., Aberle, H., Kemler, R. (1994). β-catenin mediates the interaction of the cadherin-catenin complex with epidermal growth factor receptor. J. Cell Biol. 127, 1375-1380.
91. Becker, K. -F., Atkinson, M. J., Reich, U., Becker, I., Nekarda, H., Siewert, J. R., Hofler, H. (1994) E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res. 54, 3845-3852.
92. Kawanishi, J., Kato, J., Sasaki, K., Fujii, S., Watanabe, N., Niitsu, Y. (1995) Loss of E-cadherin-dependent cell-cell adhesion due to mutation of the b-catenin gene in a human cancer cell line, HSC-39. Mol. Cell Biol. 15, 1175-1181.
93. Salgaller, M. L., Weber, J. S., Koenig, S., Yannelli, J. R., Rosenberg, S. A. (1994) Generation of specific anti-melanoma reactivity by stimulation of human tumor-infiltrating lymphocytes with MAGE-1 synthetic peptide. Cancer Immunol. Immunother. 39, 105-116.
94. Visseren, M. J., Van Elsas, A., van der Voort, E. I., Ressing, M. E., Kast, W. M., Schrier, P. I., Melief, C. J. (1995) CTL specific for the tyrosinase autoantigen can be induced from healthy donor blood to lyse melanoma cells. J. Immunol. 154, 3991-3998.
95. Rivoltini, L., Kawakami, Y., Sakaguchi, K., Southwood, S., Sette, A., Robbins, P. F., Marincola, F. M., Salgaller, M. L., Yannelli, J. R., Appella, E. (1995) Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1. J. Immunol. 154, 2257-2265.
96. Salgaller, M. L., Afshar, A., Marincola, F. M., Rivoltini, L., Kawakami, Y., Rosenberg, S. A. (1995) Recognition of multiple epitopes in the human melanoma antigen gp100 by peripheral blood lymphocytes stimulated in vitro with synthetic peptides. Cancer Res. 55, 4972-4979.
97. Lipford, G. B., Bauer, S., Wagner, H., Heeg, K. (1995) Peptide engineering allows cytotoxic T-cell vaccination against human papilloma virus tumour antigen, E6. Immunol. 84, 298-303.
98. Lipford, G. B., Bauer, S., Wagner, H., Heeg, K. (1995) In vivo CTL induction with point-substituted ovalbumin peptides: immunogenicity correlates with peptide-induced MHC class I stability. Vaccine 13, 313-320.
99. Parkhurst, M. R., Salgaller, M., Southwood, S., Robbing, P., Sette, A., Rosenberg, S. A., Kawakami, Y. (1996) Improved induction of melanoma reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A0201 binding residues. J. Immunol. in press.
100. Cole, D. J., Weil, D. P., Shamamian, P., Rivoltini, L., Kawakami, Y., Topalian, S., Jennings, C., Eliyahu, S., Rosenberg, S. A., Nishimura, M. I. (1994) Identification of MART-1-specific T-cell receptors: T cells utilizing distinct T-cell receptor variable and joining regions recognize the same tumor epitope. Cancer Res. 54, 5265-5268.
101. Cole, D. J., Weil, D. P., Shilyansky, J., Custer, M., Kawakami, Y., Rosenberg, S. A., Nishimura, M. I. (1995) Characterization of the functional specificity of a cloned T-cell receptor heterodimer recognizing the MART-1 melanoma antigen. Cancer Res 55, 746-752.
102. Romero, P., Pannetier, C., Herman, J., Jongeneel, C. V., Cerottini, J-C., Coulie, P. G. (1995) Multiple specificities in the repertoire of a melanoma patient's cytolytic T lymphocytes directed against tumor antigen MAGE-1.A1. J. Exp. Med. 182, 1019-1028.
103. + ovarian cancers. J. Immunol. 152, 4993-4999.
104. Ashton-Rickardt, P. G., Bandeira, A., Delaney, J. R., Van Kaer, L., Pircher, H. P., Zinkernagel, R. M., Tonegawa, S. (1994) Evidence for a differential avidity model of T cell selection in the thymus [see comments]. Cell 76, 651-663.
105. Jameson, S. C., Hogquist, K. A., Bevan, M. J. (1994) Specificity and flexibility in thymic selection. Nature 369, 750-752.
106. Ashton-Rickardl, P. G., Tonegawa, S. (1994) A differential-avidity model for T-cell selection. Immunol. Today 15, 362-366.
107. Sercarz, E. E., Lehmann, P. V., Ametani, A., Benichou, G., Miller, A., Moudgil, K. (1993) Dominance and crypticity of T cell antigenic determinants. Annu. Rev. Immunol. 11, 729-766.
108. Moudgil, K. D., Sercarz, E. E. (1994) Can antitumor immune responses discriminate between self and nonself? Immunol. Today 15, 353-355.
109. Pircher, H., Rohrer, U. H., Moskophidis, D., Zinkernagel, R. M., Hengartner, H. (1991) Lower receptor avidity required for thymic clonal deletion than for effector T-cell function. Nature 351, 482-485.
110. Fairchild, P. J., Wraith, D. C. (1996) Lowering the tone: mechanisms of immunodominance among epitopes with low affinity for MHC. Immunol. Today 17, 80-86.
111. Houghton, A. N. (1994) Commentary. Cancer antigens: Immune recognition of self and altered self. J. Exp. Med. 180, 1-4.
112. Nanda, N. K., Sercarz, E. E. (1995) Induction of anti-self-immunity to cure cancer. Cell 82, 13-17.
113. Nordlund, J. J., Kirkwood, M., Forget, B. M., Milton, C., Albert, D. M., Lerner, A. B. (1983) Vitiligo in patients with metastatic melanoma: A good prognostic sign. J. An. Acad. Dermatol. 9, 689-695.
114. Bystryn, J.-C, Rigel, D., Friedman, R. J., Kopf, A. (1987) Prognostic significance of hypopigmentation in malignant melanoma. Arch. Dermatol. 123, 1053-1055.
115. Richards, J. M., Mehta, N., Ramming, K., Skosey, P. (1992) Sequential chemoimmunotherapy in the treatment of metastatic melanoma. J. Clin. Oncol. 10, 1338-1343.
116. Hara, I., Takechi, Y., Houghton, A. N. (1995) Implicating a role for immune recognition of self in tumor rejection: passive immunization against the Brown locus protein. J. Exp. Med. 182, 1609-1614.
117. Young, J. W., Inaba, K. (1996) Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity. J. Exp. Med. 183, 7-11.
118. Zhai, Y., Yang, J. C., Kawakami, Y., Spiess, P., Wadsworth, S. C., Cardoza, L. M., Couture, L. A., Smith, A. E., Rosenberg, S. A. (1996) Antigen-specific tumor vaccines: Development and characterization of recombinant adenoviruses encoding MART-1 or gp100 for cancer therapy. J. Immunol. 156, 770-782.
119. Bronte, V., Tsung, K., Rao, J. B., Chen, P. W., Wang, M., Rosenberg, S. A., Restifo, N. P. (1995) IL-2 enhances the function of recombinant poxvirus-based vaccines in the treatment of established pulmonary metastases. J. Immunol. 154, 5282-5292.
120. Irvine, K., Rao, J., Rosenberg, S., Restifo, N. (1996) Cytokine enhancement of DNA immunization leads to treatment of established pulmonary metastases. J. Immunol. 156, 238-245.